Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2014, Article ID 120714, 5 pages
http://dx.doi.org/10.1155/2014/120714
Case Report

A Double Hit CD10-Negative B-Cell Lymphoma with t(3;8)(q27;q24) Leading to Juxtaposition of the BCL6 and MYC Loci Associated with Good Clinical Outcome

1Department of Haematology, University Hospitals of Leicester, Leicester LE1 5WW, UK
2Ernest and Helen Scott Haematological Research Institute and Department of Biochemistry, University of Leicester, Leicester LE1 9HN, UK
3Christian-Albrechts-University Kiel and Universitatsklinikum Schleswig-Holstein, Campus Kiel, Arnold Heller Straße 3, 24105 Kiel, Germany
4Ernest and Helen Scott Haematological Research Institute and Department of Cancer Studies and Molecular Medicine, University of Leicester, Leicester LE1 9HN, UK

Received 8 August 2014; Accepted 15 September 2014; Published 1 October 2014

Academic Editor: Takashi Sonoki

Copyright © 2014 Lucinda Sanders et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Barnes, A. S. LaCasce, Y. Feng et al., “Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis,” Annals of Oncology, vol. 22, no. 8, pp. 1859–1864, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. G. M. Mead, M. R. Sydes, J. Walewski et al., “An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study,” Annals of Oncology, vol. 13, no. 8, pp. 1264–1274, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. E. S. Jaffe, N. L. Harris, H. Stein, and J. W. Vardiman, World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, IARC Press, Lyon, France, 2001.
  4. K. Kelemen, R. M. Braziel, K. Gatter, T. C. Bakke, S. Olson, and G. Fan, “Immunophenotypic variations of Burkitt lymphoma,” The American Journal of Clinical Pathology, vol. 134, no. 1, pp. 127–138, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Leventaki, V. Rodic, S. R. Tripp et al., “TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases,” British Journal of Haematology, vol. 158, no. 6, pp. 763–771, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. S. S. Dave, K. Fu, G. W. Wright et al., “Molecular diagnosis of Burkitt's lymphoma,” The New England Journal of Medicine, vol. 354, no. 23, pp. 2431–42, 2006. View at Google Scholar
  7. J. Richter, M. Schlesner, S. Hoffmann et al., “Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing,” Nature Genetics, vol. 44, no. 12, pp. 1316–1320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. S. M. Aukema, M. Kreuz, C. W. Kohler et al., “Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma,” Haematologica, vol. 99, no. 4, pp. 726–735, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. A. A. Alizadeh, M. B. Eisen, R. E. Davis et al., “Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling,” Nature, vol. 403, no. 6769, pp. 503–511, 2000. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Shipp, K. N. Ross, P. Tamayo et al., “Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning,” Nature Medicine, vol. 8, no. 1, pp. 68–74, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. S. M. Aukema, R. Siebert, E. Schuuring et al., “Double-hit B-cell lymphomas,” Blood, vol. 117, no. 8, pp. 2319–2331, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. R. K. Pillai, M. Sathanoori, S. B. van Oss, and S. H. Swerdlow, “Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas,” The American Journal of Surgical Pathology, vol. 37, no. 3, pp. 323–332, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Hummel, S. Bentink, H. Berger et al., “A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling,” The New England Journal of Medicine, vol. 354, no. 23, pp. 2419–2430, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Klapper, M. Kreuz, C. W. Kohler et al., “Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma,” Blood, vol. 119, no. 8, pp. 1882–1887, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. R. A. Ventura, J. I. Martin-Subero, M. Jones et al., “FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue,” Journal of Molecular Diagnostics, vol. 8, no. 2, pp. 141–151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. P. M. Kluin, N. L. Harris, and H. Stein, “B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma,” in WHO Classification of Tumour of Haematopoietic and Lymphoid Tissues, S. H. Swerdlow, E. Campo, N. L. Harris et al., Eds., IARC Press, Lyon, France, 2008. View at Google Scholar
  17. J. T. Sandlund, M. B. Kastan, W. Kennedy et al., “A subtle t(3;8) results in plausible juxtaposition of MYC and BCL6 in a child with Burkitt lymphoma/leukemia and ataxia-telangiectasia,” Cancer Genetics and Cytogenetics, vol. 168, no. 1, pp. 69–72, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Motlló, J. Grau, J. Juncà et al., “Translocation (3;8)(q27;q24) in two cases of triple hit lymphoma,” Cancer Genetics and Cytogenetics, vol. 203, no. 2, pp. 328–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Bertrand, C. Bastard, C. Maingonnat et al., “Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas,” Leukemia, vol. 21, no. 3, pp. 515–523, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. H.-Y. Wang, A. D. Bossler, A. Schaffer et al., “A novel t(3;8)(q27;q24.1) simultaneously involving both the BCL6 and MYC genes in a diffuse large B-cell lymphoma,” Cancer Genetics and Cytogenetics, vol. 172, no. 1, pp. 45–53, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Sonoki, H. Tatetsu, A. Nagasaki, and H. Hata, “Molecular cloning of translocation breakpoint from der(8)t(3;8)(q27;q24) defines juxtaposition of downstream of C-MYC and upstream of BCL6,” International Journal of Hematology, vol. 86, no. 2, pp. 196–198, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. U. Bacher, T. Haferlach, T. Alpermann, W. Kern, S. Schnittger, and C. Haferlach, “Several lymphoma-specific genetic events in parallel can be found in mature B-cell neoplasms,” Genes Chromosomes and Cancer, vol. 50, no. 1, pp. 43–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Tzankov, Z. Y. Xu-Monette, M. Gerhard et al., “Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP,” Modern Pathology, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. C. P. Hans, D. D. Weisenburger, T. C. Greiner et al., “Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray,” Blood, vol. 103, no. 1, pp. 275–282, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. R. E. Culpin, M. Sieniawski, B. Angus et al., “Prognostic significance of immunohistochemistry-based markers and algorithms in immunochemotherapy-treated diffuse large B cell lymphoma patients,” Histopathology, vol. 63, no. 6, pp. 788–801, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. S. K. Turakhia, B. T. Hill, S. D. Dufresne et al., “Aggressive B-cell lymphomas with translocations involving BCL6 and MYC have distinct clinical-pathologic characteristics,” American Journal of Clinical Pathology, vol. 142, no. 3, pp. 339–346, 2014. View at Publisher · View at Google Scholar